Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC
about
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?"Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in micePhysiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance.Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapseEffects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis usersHuman Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.Cannabinoid signaling in health and disease.Sex differences in the subjective effects of oral Δ9-THC in cannabis users.The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms.Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
P2860
Q27025612-B0ADCEE8-5E01-4456-AA8F-7A0DB3ECCD16Q34055910-F556BF9E-97A0-4160-A302-71996A861C1BQ34205968-8B39013E-80D3-44CF-862E-C52C2C697D35Q34223229-15F7D0F9-81C2-4878-A966-D52098B83D4BQ35257856-B0759C04-047E-42B3-839B-BA92F733F969Q35840095-D0E001C1-AB86-4E9E-810E-0B66F82FB10BQ35911283-3712D789-08E8-4608-8B7D-63FB23E5ADB1Q36339147-A3C2F466-B56B-4A34-A3F7-54B39050D580Q36927776-A78B92BE-4AFC-4BB1-ACE5-49E6370F0A5DQ37635636-1B568314-FE40-4418-A9A0-2D9DFEABEA3CQ38856900-827DD6C8-F593-4DD7-B074-7E0997841938Q39163671-4B4D074F-DDAA-45E3-BC57-38C91759CE87Q40094296-18F0FCB6-7796-4820-B80E-DB29E4A5E2CCQ43809543-D23AC9FA-1B4B-4AF6-947D-71F52C3CD7A9Q47943756-B3BA846A-5FD0-4C41-93D8-FE3B57077BF7Q47958585-E873FF60-6CE2-420A-9BAB-C18CB0A671BC
P2860
Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@ast
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@en
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@nl
type
label
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@ast
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@en
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@nl
prefLabel
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@ast
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@en
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@nl
P2093
P2860
P1476
Separate and combined effects ...... n humans discriminating Δ⁹-THC
@en
P2093
Joshua A Lile
Lon R Hays
Thomas H Kelly
P2860
P356
10.1016/J.DRUGALCDEP.2010.11.019
P577
2011-01-11T00:00:00Z